The Cost-Effectiveness of Acetaminophen, NSAIDs, and Selective COX-2 Inhibitors in the Treatment of Symptomatic Knee Osteoarthritis
- 1 March 2003
- journal article
- research article
- Published by Elsevier BV in Value in Health
- Vol. 6 (2), 144-157
- https://doi.org/10.1046/j.1524-4733.2003.00215.x
Abstract
No abstract availableKeywords
This publication has 46 references indexed in Scilit:
- Drug switching patterns among patients taking non-steroidal anti-inflammatory drugs: a retrospective cohort study of a general practitioners database in the United KingdomPharmacoepidemiology and Drug Safety, 2001
- Economic Evaluation of Celecoxib, a New Cyclo-Oxygenase 2 Specific Inhibitor, in SwitzerlandPharmacoEconomics, 2001
- Gastrointestinal Toxicity With Celecoxib vs Nonsteroidal Anti-inflammatory Drugs for Osteoarthritis and Rheumatoid ArthritisJAMA, 2000
- Estimating CE Ratios under Second-order UncertaintyMedical Decision Making, 1997
- Costs, effects and C/E‐ratios alongside a clinical trialHealth Economics, 1994
- Variation in the risk of peptic ulcer complications with nonsteroidal antiinflammatory drug therapyArthritis & Rheumatism, 1993
- Trends in the utilization of non-steroidal anti-inflammatory drugs in the United States, 1986–1990Journal of Clinical Epidemiology, 1992
- Nonsteroidal Antiinflammatory Drugs and Gastrointestinal Hospitalizations in Saskatchewan: A Cohort StudyEpidemiology, 1992
- Upper gastrointestinal bleeding in relation to previous use of analgesics and non-steroidal anti-inflammatory drugsThe Lancet, 1991
- Robust Estimation of a Location ParameterThe Annals of Mathematical Statistics, 1964